Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
240
Trial Sponsor
Clinical Trial Start Date
2013
0Primary Completion Date
2013
0Study Completion Date
2013
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Basic Science0
Intervention Type
Drug0
Interventional Trial Phase
Phase 10
Official Name
An Open Label, Randomized, Single Dose and Multiple Dose Trial to Assess the Pharmacokinetics of Obeticholic Acid (OCA)0
Last Updated
December 5, 2013
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
None (Open Label)0
Other attributes
Intervention Treatment
OCA 5 mg0
OCA 25 mg0
OCA 10 mg0
Study summary
This is a single center, open label, randomized, parallel design, single and multiple dose trial to evaluate the pharmacokinetics(PK), safety and tolerability of obeticholic acid (OCA).
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
